Microbial Tryptophan Metabolism Activates Host Lysosomal Activity to Facilitate Lipid Breakdown and Ameliorate Hepatic Steatosis

Kenan Zhang, Zihan Luo, Yan Li, Yan Chen, Lang Wang, Yanan Liu, Ruizhi Yang, Quan Li, Jiahao Zhao, Bin Qi, Zhao ShanbioRxiv 2025 · DOI

Abstract

Lysosomes are central to lipid metabolism, yet how gut microbiota-derived metabolites regulate lysosomal function to influence host lipid homeostasis remains unknown. Here, we identify an evolutionarily conserved mechanism in which bacterial tryptophan metabolism activates lysosomal activity to promote lipid breakdown. By developing a lysosomal-responsive lipid reporter in C. elegans to screen for bacterial metabolic states that modulate host lipid storage, we discover that E. coli tryptophan catabolism via tryptophanase TnaA induces lysosomal lipid chaperone LBP-8, driving lipid mobilization. Moreover, tryptophan metabolites enhanced lysosomal acidification and degradation capacity, while genetic disruption of lysosomal regulators reversed these effects. Strikingly, bacterial tryptophan metabolism further promoted mitochondrial β-oxidation through lysosomal lipase activity. This pathway was conserved in mammalian hepatocytes, where E. coli-derived tryptophan metabolites enhance lysosomal function and reduce lipid accumulation. In high-fat diet mice, restoring gut bacterial tryptophan metabolism alleviated hepatic steatosis. Our work uncovers microbiota-regulated lysosomal activation as a critical axis in lipid homeostasis, highlighting its potential as a therapeutic target for metabolic disorders linked to lysosomal dysfunction.

Introduction

Non-alcoholic fatty liver disease (NAFLD), or hepatic steatosis, is a global health crisis driven by the accumulation of lipids in the liver. While the gut microbiota is known to play a significant role in host metabolism, the specific "molecular handshakes" between bacterial metabolites and cellular organelles have remained elusive.

Lysosomes are often viewed simply as the cell’s degradative centers, but they are actually sophisticated metabolic hubs containing enzymes necessary to break down complex lipids into free fatty acids. This research addresses the challenge of identifying specific microbial signals that activate host lysosomes to process fat and determines whether this mechanism can be harnessed to treat metabolic disorders.

Methods

The study employed a multi-model approach bridging simple organisms and mammalian systems:

  • C. elegans Reporter System: A transgenic roundworm reporter was developed using the promoter of lbp-8, a gene encoding a lysosomal lipid chaperone. Pathway activity was monitored via GFP expression.
  • Bacterial Genetic Screening: The researchers screened the E. coli Keio collection—a library of nearly 4,000 single-gene knockouts—to identify bacterial genes essential for triggering the host lipid-clearing response.
  • Advanced Imaging: Confocal microscopy and pH-sensitive fluorescent proteins (pHTomato) were used to monitor lysosomal acidification and structural remodeling in real-time.
  • RNA-sequencing & Pathway Analysis: RNA-seq on C. elegans identified differentially expressed genes (DEGs) under various bacterial diets, with KEGG analysis mapping these to the lysosome as a primary responder.
  • Mammalian Validation: Findings were tested in human Huh7 liver cells and a high-fat diet (HFD) mouse model. Mice were treated with antibiotics and re-colonized with specific E. coli strains to isolate metabolic effects.

Key Results

The TnaA-Tryptophan Axis

The genetic screen identified tryptophanase (TnaA) as the critical bacterial enzyme. TnaA catabolizes tryptophan into indole, pyruvate, and ammonium. Without this bacterial enzyme, the host cannot activate its fat-burning machinery. In C. elegans, tryptophan supplementation significantly reduced lipid stores, but this effect was abolished if the bacteria lacked tnaA or if host lysosomal regulators (like cup-5) were silenced.

Lysosomal Activation and Lipid Mobilization

Tryptophan metabolites actively enhance lysosomal function by increasing acidification and boosting proteolytic capacity. The study highlights LBP-8 as a vital chaperone that moves fatty acids from the lysosome to the mitochondria. This ensures that once fat is broken down, it is immediately sent for β-oxidation. Bacterial tryptophan metabolism specifically induced the expression of acs-2, a key gene for mitochondrial β-oxidation, increasing the host's overall fat-burning rate.

Conservation and Therapeutic Potential

This microbiota-lysosome-lipid axis is conserved from worms to humans. In human liver cells, tryptophan-supplemented supernatants increased lysosomal acidity by 2-3 fold. Most significantly, in HFD-fed mice, restoring gut E. coli capable of metabolizing tryptophan led to a significant reduction in liver weight and a visible decrease in fat vacuoles in liver tissue, as confirmed by Oil Red O and H&E staining.

Discussion and Future Directions

This research establishes a clear link between microbial tryptophan metabolites and lysosomal activation, offering a new perspective on host-microbe crosstalk. However, several questions remain:

  • Receptor Identification: The specific host receptor that senses these bacterial metabolites to initiate the lysosomal response is yet to be identified.
  • Metabolite Specificity: Tryptophan catabolism produces several molecules; future work must determine if a single metabolite or a specific cocktail is the primary driver.
  • In Vivo Imaging: Technical limitations currently prevent direct measurement of lysosomal pH inside living mouse livers, requiring reliance on indirect markers.

By fine-tuning the chemical conversation between the gut and host cells, this work opens the door for metabolic-focused probiotics to treat fatty liver disease.

Summary updated

Abstract

Abstract Lysosomes are central to lipid metabolism, yet how gut microbiota-derived metabolites regulate lysosomal function to influence host lipid homeostasis remains unknown. Here, we identify an evolutionarily conserved mechanism in which bacterial tryptophan metabolism activates lysosomal activity to promote lipid breakdown. By developing a lysosomal-responsive lipid reporter in C. elegans to screen for bacterial metabolic states that modulate host lipid storage, we discover that E. coli tryptophan catabolism via tryptophanase TnaA induces lysosomal lipid chaperone LBP-8, driving lipid mobilization. Moreover, tryptophan metabolites enhanced lysosomal acidification and degradation capacity, while genetic disruption of lysosomal regulators reversed these effects. Strikingly, bacterial tryptophan metabolism further promoted mitochondrial β-oxidation through lysosomal lipase activity. This pathway was conserved in mammalian hepatocytes, where E. coli -derived tryptophan metabolites enhance lysosomal function and reduce lipid accumulation. In high-fat diet mice, restoring gut bacterial tryptophan metabolism alleviated hepatic steatosis. Our work uncovers microbiota-regulated lysosomal activation as a critical axis in lipid homeostasis, highlighting its potential as a therapeutic target for metabolic disorders linked to lysosomal dysfunction. Significance We uncover a conserved mechanism by which microbial tryptophan metabolism enhances lysosomal function to maintain host lipid homeostasis. Specifically, we demonstrate that bacterial tryptophan catabolism—via the enzyme TnaA—promotes lysosomal acidification, proteolytic capacity, and structural remodeling in C. elegans , driving lipid breakdown through the lysosomal chaperone LBP-8. This activation boosts mitochondrial β-oxidation and reduces lipid storage. Importantly, the same pathway operates in mammalian hepatocytes and in a high-fat diet mouse model, where restoring bacterial tryptophan metabolism markedly alleviates hepatic steatosis. Our findings bridge microbial metabolism and lysosomal dynamics, offering fresh insights into host–microbe crosstalk and metabolic regulation. Highlights TnaA-mediated bacterial tryptophan catabolism promotes lipid mobilization via lysosomal chaperone. Bacterial tryptophan metabolites boost lysosomal function, lipid breakdown, and mitochondrial β-oxidation. Conserved microbiota-lysosome-lipid axis from worms to mammalian liver. Restoring gut bacterial tryptophan metabolism alleviates hepatic steatosis in high-fat diet mice.
BibTeX
@misc{zhang2025microbial,
  author = {Kenan Zhang and Zihan Luo and Yan Li and Yan Chen and Lang Wang and Yanan Liu and Ruizhi Yang and Quan Li and Jiahao Zhao and Bin Qi and Zhao Shan},
  title = {{Microbial Tryptophan Metabolism Activates Host Lysosomal Activity to Facilitate Lipid Breakdown and Ameliorate Hepatic Steatosis}},
  year = {2025},
  doi = {10.1101/2025.06.28.662086},
  howpublished = {bioRxiv},
}
Figure